Clinical Trial Update: A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term safety of Vedolizumab given subcutaneously in adults with Ulcerative Colitis and Crohn's Disease; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (subcutaneous) (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Colitis, Ulcerative, Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-04-03